SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-122337
Filing Date
2019-04-26
Accepted
2019-04-26 16:09:03
Documents
11
Period of Report
2019-05-29
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d687564ddef14a.htm DEF 14A 420137
2 GRAPHIC g6875641.jpg GRAPHIC 7263
3 GRAPHIC g6875642.jpg GRAPHIC 7163
4 GRAPHIC g687564a.jpg GRAPHIC 6094
5 GRAPHIC g687564a1.jpg GRAPHIC 518
6 GRAPHIC g687564b.jpg GRAPHIC 855
7 GRAPHIC g687564c.jpg GRAPHIC 922
8 GRAPHIC g687564d.jpg GRAPHIC 1015
9 GRAPHIC g687564g38t37.jpg GRAPHIC 18190
10 GRAPHIC g687564g80o53.jpg GRAPHIC 18823
11 GRAPHIC g687564g99d47.jpg GRAPHIC 41477
  Complete submission text file 0001193125-19-122337.txt   563557
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32979 | Film No.: 19771841
SIC: 2834 Pharmaceutical Preparations